ENVISION HEALTHCARE CORPORATION (NYSE:EVHC) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01. Entry into a Material Definitive Agreement.
Tranche C Incremental Borrowing
On June 23, 2017, Envision Healthcare Corporation (the Company)
incurred incremental term loan borrowings in an aggregate
principal amount of $500 million, maturing on December 1, 2023
(the Supplemental Tranche C Term Loans). The Company will use
these borrowings to fund acquisitions, to repay amounts
outstanding under its asset-based revolving credit facility, and
to pay fees and expenses related to the financing. The
Supplemental Tranche C Term Loans were borrowed to the Increase
Supplement, dated as of June 23, 2017 (the Increase Supplement),
by and among the Company, the increasing lenders party thereto,
JPMorgan Chase Bank, N.A., as administrative agent and collateral
agent, and each of the other parties thereto, which supplements
the Companys existing Amended and Restated Credit Agreement,
dated as of December 1, 2016, among the Company, the banks,
financial intuitions and lenders from time to time party thereto,
and JPMorgan Chase Bank, N.A. (JPMorgan Chase), as administrative
agent and collateral agent (the Term Loan Facility).
incurred incremental term loan borrowings in an aggregate
principal amount of $500 million, maturing on December 1, 2023
(the Supplemental Tranche C Term Loans). The Company will use
these borrowings to fund acquisitions, to repay amounts
outstanding under its asset-based revolving credit facility, and
to pay fees and expenses related to the financing. The
Supplemental Tranche C Term Loans were borrowed to the Increase
Supplement, dated as of June 23, 2017 (the Increase Supplement),
by and among the Company, the increasing lenders party thereto,
JPMorgan Chase Bank, N.A., as administrative agent and collateral
agent, and each of the other parties thereto, which supplements
the Companys existing Amended and Restated Credit Agreement,
dated as of December 1, 2016, among the Company, the banks,
financial intuitions and lenders from time to time party thereto,
and JPMorgan Chase Bank, N.A. (JPMorgan Chase), as administrative
agent and collateral agent (the Term Loan Facility).
The Increase Supplement increased the Supplemental Tranche C Term
Loan commitments under the Term Loan Facility from $0 to $500
million. JPMorgan Chase acted as the sole lead arranger and sole
bookrunner for the Supplemental Tranche C Term Loans. The
Supplemental Tranche C Term Loans bear interest at the same rate
and have the same terms as the Companys Tranche C Term Loans
maturing on December 1, 2023 that were outstanding under the Term
Loan Facility prior to the effectiveness of the Increase
Supplement.
Loan commitments under the Term Loan Facility from $0 to $500
million. JPMorgan Chase acted as the sole lead arranger and sole
bookrunner for the Supplemental Tranche C Term Loans. The
Supplemental Tranche C Term Loans bear interest at the same rate
and have the same terms as the Companys Tranche C Term Loans
maturing on December 1, 2023 that were outstanding under the Term
Loan Facility prior to the effectiveness of the Increase
Supplement.
The foregoing description of the Increase Supplement does not
purport to be a complete description and is qualified in its
entirety by reference to the full text thereof, which is attached
as Exhibit 10.1 to this report and is incorporated herein by
reference.
purport to be a complete description and is qualified in its
entirety by reference to the full text thereof, which is attached
as Exhibit 10.1 to this report and is incorporated herein by
reference.
Item 2.03. Creation of a Direct Financial Obligation or an
Obligation under an Off-Balance Sheet Arrangement of a
Registrant.
Obligation under an Off-Balance Sheet Arrangement of a
Registrant.
The information set forth in Item 1.01 of this Current Report on
Form 8-K is incorporated by reference into this Item 2.03.
Form 8-K is incorporated by reference into this Item 2.03.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No.
|
Description of Exhibit
|
|
|
10.1
|
Increase Supplement, dated as of June 23, 2017, by and
among the Company, the increasing lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, and each of the other parties thereto. |
Envision Healthcare Corp ExhibitEX-10.1 2 evhc8k20170627ex101.htm EXHIBIT 10.1 Exhibit Exhibit 10.1EXECUTION VERSIONINCREASE SUPPLEMENTINCREASE SUPPLEMENT,…To view the full exhibit click here
